Health trending topics
981 results
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is currently up (+107.78%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List. Click Here to find out what other Investors are …SBWire · 5/22/2013
Alkermes plc (NASDAQ:ALKS) is currently up (+118.15%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a company that …SBWire · 5/21/2013
The stock price of Vertex Pharmaceuticals (VRTX) spiked up 3% in early Wednesday trading after the company announced its Q1 2013 financials the previous evening, beating analyst expectations on revenue and net earnings. However, by the end of the …Seeking Alpha · 5/3/2013
Zacks lowered shares of Vertex Pharmaceuticals (NASDAQ: VRTX) from an outperform rating to a neutral rating in a research report released on Wednesday morning, Analyst Ratings.Net reports. Zacks currently has $92.20 price target on the stock. VRTX …Zolmax News · 5/17/2013
Shares of Vertex Pharmaceuticals Incorporated (VRTX) soared Thursday and kept skyrocketing on Friday after the company announced positive results of a drug trial involving a new treatment for cystic fibrosis. Shares jumped as much as 58 percent Friday ...Value Walk · 4/19/2013
May 03, 2013 (ACCESSWIRE-TNW via COMTEX) -- New York, NY -- (ACCESSWIRE) -- 05/3/2013 -- Equity Profile Report expands its NASDAQ Active Stock Watch List adding Facebook, Inc. (NASDAQ:FB) , Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) …Marketwatch · 5/3/2013
Apr 19, 2013 (ACCESSWIRE-TNW via COMTEX) -- New York, NY -- (ACCESSWIRE) -- 04/19/2013 -- Growing Stock Report initiates a NASDAQ Gainers Weekly Watch List adding Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) , Overstock.com Inc.Marketwatch · 4/19/2013
If all looks good, the stock can advance to your next stage of analysis. For example, a key market targeted by Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is cystic fibrosis. The disease impacts around 30 …INSIDER MONKEY · 5/13/2013
EXCLUSIVE OFFER: Jim Cramer's Protege, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass. Vertex Pharmaceuticals Incorporated engages in discovering, developing ...TheStreet.com · 5/16/2013
Goldman Sachs upgraded shares of Vertex Pharmaceuticals (NASDAQ: VRTX) from a sell rating to a neutral rating in a research report released on Friday morning, TheFlyOnTheWall.com reports. Goldman Sachs currently has $86.00 price target on the …Daily Political · ByPatrick Bannon · 4/23/2013
You might also like
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback